Cargando…
Evolution in functionality of a metastatic pancreatic neuroendocrine tumour (pNET) causing Cushing’s syndrome: treatment response with chemotherapy
BACKGROUND: We report the case of a patient who had a non-functional metastatic pancreatic neuroendocrine tumour (pNET), which changed in functionality during the course of the disease. This case demonstrates the effectiveness of conventional cytotoxic chemotherapy in the management of select group...
Autores principales: | Rajeev, Surya Panicker, McDougall, Steffan, Terlizzo, Monica, Palmer, Daniel, Daousi, Christina, Cuthbertson, Daniel J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149042/ https://www.ncbi.nlm.nih.gov/pubmed/25151270 http://dx.doi.org/10.1186/1472-6823-14-70 |
Ejemplares similares
-
An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs)
por: Alonso-Gordoa, Teresa, et al.
Publicado: (2015) -
Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know
por: de Ponthaud, Charles, et al.
Publicado: (2021) -
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors
por: Chu, Pei-Yi, et al.
Publicado: (2017) -
OR16-03 Epigenetic Studies Of Pancreatic Neuroendocrine Tumours (PNETs) Reveal Decreased DNA Hydroxymethylation In Non-functioning PNETs But Not Insulinomas
por: English, Katherine A, et al.
Publicado: (2023) -
Congenital sacrococcygeal PNET and chemotherapy
por: Hawkes, Colin Patrick, et al.
Publicado: (2012)